13.2.3. Activators of Intra-iAβ-Cleaving Capabilities of BACE1 and/or BACE2 Would Constitute Potent AD Drugs; Once-in-a-Lifetime Treatment Could Be Sufficient to Prevent the Disease or Arrest Its Progression. The gene discussed is BACE2; the disease is Alzheimer disease.